Is DocGo Inc. (DCGO) the Best Quality Penny Stock to Buy According to Hedge Funds?
We recently published a list of 11 Best Quality Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where DocGo Inc. (NASDAQ:DCGO) stands against other best quality penny stocks.
The quality factor in stocks refers to companies with strong fundamentals, financial stability, and reliable performance, with an aim for resilience rather than speculative growth. Quality stocks can be proxied through several metrics – as Hsu, Kalesnik, and Kose put it in their 2019 paper:
'Quality as an investment factor is systematically associated with persistent profitability, low leverage, and stable earnings growth.'
Besides that, these stocks often exhibit high revenue growth, good management practices, and a sustainable competitive advantage reflected through double-digit return on invested capital. The attractiveness of quality stocks consists in their lower volatility, defense capabilities, and ability to outperform the broad market during recessions or periods of pronounced uncertainty.
In the context of penny stocks, the quality factor becomes elusive, as most penny stocks inherently lack stable fundamentals, carry higher volatility, and often possess weaker balance sheets. Nevertheless, it is still positive to find quality penny stocks, which results in a powerful blend of high growth and high return features with resilience and consistency of growth. The best quality penny stocks are likely to deliver robust high growth even during market downturns and outperform the benchmark by a wide margin. The positive effect of the quality factor on stock returns has been proven by leading researchers, such as the Asness, Frazzini, and Pedersen (2019) paper. Here's an excerpt from the paper:
'High-quality stocks have higher risk-adjusted returns than low-quality stocks… A quality-minus-junk (QMJ) factor earns significant risk-adjusted returns in U.S. and global stocks.'
READ ALSO: 11 Best Fundamentally Strong Penny Stocks to Buy Now.
The primary takeaway for readers is that incorporating quality penny stocks in a portfolio can boost the overall return of the portfolio per unit of risk, which has always been the ultimate goal of many successful investors. However, the quality factor tends to perform better in specific market periods, and we believe the US stock market has entered such a period for the following reasons. First, smart money tends to flock into quality stocks with stable profitability, cash flows, and strong revenue growth in periods of uncertainty. The US stock market is currently shaken by the Trump tariffs. The uncertainty persists as of April 1, as evidenced by the VIX volatility index being at a value of 31, more than 50% above the daily 200 moving average.
Second, there are reasons to expect a significant deceleration in GDP and earnings growth in the first half of 2025, as the cuts in public spending as well as the tariffs uncertainty are a huge headwind for private spending and Capex – CEOs tend to be reluctant to invest heavily into the business when they lack visibility for the near-term. Consequently, the odds are that Q1 2025 earnings, once reported, will show a sequential slowdown in growth. FactSet Insight showed that the Q2 2025 earnings growth for the US stock market is expected at +7.2% YoY, significantly below the +18.2% actual for the previous 4Q 2024. Keep in mind that there's still potential for actual growth to come even lower than the +7.2% estimate.
Last but not least, the S&P index remains below its daily 200 moving average, an area where nothing good tends to happen. The last time the market broke below the 200 moving average was in January 2022, which resulted in a 12-month-long bear market with an absolute drawdown of -28%, much above the current -13%. This means that the current market correction may not be over yet; if the broad market stays in red territory, it is inevitable that money will start flowing increasingly toward high-quality stocks and penny stocks, boosting their valuations. All in all, the aforementioned findings support the thesis that the quality factor will be favored over the following months, which means we might be at an opportune time to buy the best quality penny stocks.
Jaromir Chalabala/Shutterstock.com
We used a stock screener to identify companies with a share price under $5.00 that have at least 20% revenue CAGR in the last 5 years and a positive net profit margin. Then we compared the list with our proprietary database of hedge funds' ownership and included in the article the top 11 stocks with the largest number of hedge funds that own the stock as of Q4 2024. The stocks are ranked in ascending order.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().DocGo Inc. (NASDAQ:DCGO) is a provider of mobile health and medical transportation services across 31 US states and the UK. Through its extensive network of mobile units, the company offers urgent care, chronic disease management, and remote patient monitoring services directly at patients' locations. For its services, DCGO is paid by hospitals, health systems, government agencies, and corporate partners, with money that accumulates from health insurance. DCGO also ranked sixth on our recent list of 11 Best Fundamentally Strong Penny Stocks to Buy Now.
DocGo Inc. (NASDAQ:DCGO) reported Q4 2024 revenues of $120.8 million, representing a 39% decrease YoY, with the decline primarily attributed to winding down migrant-related projects. While the company maintained gross margins relative to the last year, SG&A as a percentage of revenues increased substantially in Q4, reflecting continued investments in infrastructure for future growth opportunities. The company generated $70.3 million in cash flow from operations in 2024, a significant improvement from negative $64.2 million in 2023.
DocGo Inc. (NASDAQ:DCGO) is actively transitioning from crisis response work to more sustainable, evergreen revenue streams, particularly in care gap closure programs where they achieved a world-class NPS score of 86. The company's pipeline includes 27 municipal contracts, 29 health system deals, and over 120 payer and provider opportunities, with several existing health plan partners looking to significantly expand their relationship in scope and scale. For 2025, management anticipates significantly higher cash flow from operations compared to the $70 million generated in 2024. The strong guidance for 2025 suggests that the immigration-related headwinds are in the rear-view mirror, which makes us include DCGO on our list of best penny stocks to buy.
Overall, DCGO ranks 9th on our list of best quality penny stocks to buy according to hedge funds. While we acknowledge the potential of DCGO to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than DCGO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
13 hours ago
- CNBC
Wells Fargo says tariffs to hold back stocks this year, but then sees new highs in 2026
This year could be a washout for the stock market thanks to lofty tariffs, but 2026 could mark a return to new highs, according to the Wells Fargo Investment Institute. President Donald Trump's tariffs will continue to limit upside for equities this year, as corporate earnings come under pressure from higher inflation, constrained profit margins and a slower economy, but investors can start positioning for a recovery that's likely to come next year, wrote Darrell Cronk, president of the investment institute. "Significantly surpassing the equity-market highs reached early this year has likely been delayed by the tariff-related hit to consumer and business sentiment along with the imminent economic slowdown that we expect," Cronk wrote. "Without a recession, we believe the risk of further equity-market downside — beyond lows reached in April — is likely limited while upside reward potential is significant by year-end 2026," he added. .VIX YTD mountain Volatility Index (VIX), year to date. The reasoning behind the Wells Fargo thesis is this: Positive forces expected later this year, such as tax cuts and lower interest rates, in addition to lower oil prices, should offset some of the pressure from higher tariffs, helping the U.S. avoid a recession. What's more, Cronk noted that volatility historically occurs near market bottoms. In 10 comparable periods in the past, he said, when the VIX Index topped 40, the median 18-month forward return for the S & P 500 was 30%. The VIX topped 50 at one point during the April selloff and was last trading above 16. "In real time, the uncertainties can feel so large that it is difficult to look past them, but also in each case households and businesses adjusted, and generally, returns soon followed," he wrote. "In sum, the new tariffs are significant, and uncertainty may persist for some months to come," he continued. "However, we would follow the lesson of history and lean into equities." While near-term returns may remain muted, investors should "lean into the recovery" by allocating toward quality companies, Cronk said. He prefers U.S. large caps and U.S. midcaps, anticipating the U.S. will maintain its status as the global leader both economically and, by extension, in stocks. He also said he favors developed markets excluding the U.S. over emerging markets. "We view further periods of volatility as an opportunity to lean into equities to position for the gains we expect through 2026," Cronk said.
CNBC
2 days ago
- CNBC
Wall Street's 'fear gauge' just experienced its third biggest decline ever. What it means going forward
Wall Street's so-called fear gauge recorded a steep slide over recent months. That's good news for investors looking longer term. The CBOE Volatility Index (VIX) has dropped around 35 points over the two months since President Donald Trump rolled back many of his market-roiling tariffs in April. That's the third largest decline in the VIX's history going back to 1990, according to Bespoke Investment Group data, ranking behind periods in late 2008 and mid 2020. .VIX 3M mountain The VIX over the last 3 months As the VIX has retreated, stocks have rebounded significantly from the sell-off seen in the wake of Trump's initial policy unveiling. However, Bespoke noted that stocks' climb of around 20% is relatively small compared to historical performance in the aftermath of slides of this magnitude in the VIX. "Historically, the relationship between the two would suggest a surge of more than 50% over the same period, but stocks are 'only' up 20%," the firm wrote to clients. "That makes this a pretty large outlier between options and the underlying assets they track." Looking ahead, Bespoke said this pullback in the fear gauge can be "bullish" when using a longer time horizon. For example, the largest two-month VIX drops in history have correlated with average moves for the S & P 500 of nearly 6% over the following six months and almost 12% over a year. However, Bespoke warned that traders should be willing to wait, as moves over one and three months are relatively muted. Said another way, investors focused only on near-term action will find a significant tumble in the VIX to be "not very relevant." "In other words, the easy money has been made," Bespoke wrote to clients. "But there could likely be more on the table for patient investors going forward." A short round trip Bespoke isn't the only firm watching the market action following the volatility scare. Essentially, Deutsche Bank said this has been the shortest market plunge on a volatility shock on record. Strategist Parag Thatte said in a note to clients published last week that in a typical volatility-induced jolt, equities take about two months to bottom and then another four or five months to make up losses. This time, however, the stock market has bottomed and clawed back losses in under two months. In past shocks, the S & P 500 would be down close to 10% at this point. But as of midday Tuesday, the S & P 500 is up more than 6% since Trump first announced his plan for broad and steep levies on April 2. .SPX mountain 2025-04-02 The S & P 500 since April 2
Yahoo
2 days ago
- Yahoo
The Zacks Analyst Blog Highlights Compagnie de Saint-Gobain, Natwest and Lonza
Chicago, IL – June 10, 2025 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Compagnie de Saint-Gobain - Unsponsored ADR CODYY, Natwest Group NWG and Lonza Group LZAGY. What is in play in the Global Week Ahead? Uncertainty from Washington D.C.'s tariff tactics remains rife. But investors realize: whatever U.S. President Donald Trump threatens doesn't tend to last long before he delays or backs down, meaning recent volatility has ebbed. This tendency to U-turn, dubbed the TACO trade — "Trump Always Chickens Out" — has caught on. But it's also given investors something to bank on. So, they can focus on upcoming reads on Consumer Price Inflation (CPI) and trade. (1) The TACO trade is a meaningful geopolitical concept The high-voltage volatility that shook markets in April and through May has subsided, with investors becoming accustomed to Trump's on-again-off-again approach to anything from tariffs to personal relationships — the meltdown with erstwhile DOGE chief and Tesla (TSLA) CEO Elon Musk being the latest. Wall Street's fear-gauge, the VIX index, has slipped back below the 20-line that many view as a watermark. Since Trump became the 47th president on January 20th, the index has topped 20 on 47 occasions. In the five months prior to that, it breached that level 18 times. In the last month, there have been just seven days when the VIX has popped above 20, compared with every day from April 2 "Liberation Day" to early May. If anything, the TACO trade is taking some spice out of the market. (2) Wednesday at 8:30 am EST, the May U.S. consumer inflation (CPI) data lands. Investors are hoping any rise in Wednesday's May consumer inflation report won't be as severe as feared, given Trump's erratic trade tactics. Recent data shows inflation falling close to the Federal Reserve's +2.0% target. Price pressures in manufacturing and services sectors are picking up, however. A good gauge of markets' long-term inflation view indicates only moderate concern. The inflation breakeven rate on five-year Treasury Inflation Protected Securities suggests investors believe the rate will average less than 0.3 percentage points above the target for the next five years. The Fed's most recent Beige Book showed economic activity is weakening, while costs and prices are rising across the different regions — a combination policymakers do not want to see. Traders expect the Fed to make no rate change at its June 18th meeting. (3) On Monday, macro data from Mainland China focuses markets on trade issues. Washington and Beijing's trade spat has brought a familiar issue back to the surface. China has a stranglehold on global supply of so-called rare earths, critical ingredients in almost every high-tech device out there, from cars to cruise missiles. When China cuts off supply, everything withers. The auto industry is feeling it. Suzuki suspended production of the Swift subcompact, weeks after Ford (F) did the same for its Explorer SUV. The White House has blasted Beijing for reneging on tariff rollbacks agreed in Geneva last month, but China is doing the same, lambasting the U.S. over revoked student visas and cutting-edge chip curbs. Chinese trade data on Monday will illuminate what's at stake, while inflation figures that day will show if Beijing's efforts to stoke domestic demand are working. (4) On Friday, macro data from the European Union will focus on trade there. April trade data for the European Union on Friday, June 13th could offer a reasonably clean read on where things stood as Trump's on-off tariffs began to roll out. The E.U. is firmly in the U.S. president's crosshairs. Trump has said more than once the sole purpose of the E.U. is to "take advantage" of America, on the grounds that his country boasts a $200 billion trade deficit with the bloc in goods alone, making the E.U. its second-biggest goods trade partner behind China. E.U. sales of cars, steel, pharmaceuticals and luxury goods and apparel among other things are big business. Trump on May 23rd said he would impose a 50% tariff on all E.U. imports, only to back down two days later by delaying the duties by a month after a "very nice call" with European Commission President Ursula von der Leyen. (5) On Wednesday, the U.K. government presents a spending review. Bond vigilantes know this. Britain, often a prime target for bond vigilantes that attack indebted governments for financial mismanagement, has been pushed into these traders' peripheral vision by U.S. budget concerns. The Labour government's first spending review on Wednesday could bring the UK back into the spotlight. Even if finance minister Rachel Reeves manages to slash departmental spending, this will merely highlight how few cost-cutting options she has left, Bank of America says. U.K. public debt has swelled, leaving Reeves minimal headroom to avoid breaking self-imposed fiscal rules and less able to resist tax hikes. Still, businesses and borrowers still scarred by the gilt market riot after then Prime Minister Liz Truss' 2022 mini-budget may prefer higher taxes if that lowers the odds of bond vigilantes showing up. I picked three large cap European stocks from our #1 list this week. (1) Compagnie de Saint-Gobain - Unsponsored ADR: This is a $23 a share stock, with a market capitalization of $57.5B. The company operates in the Zacks Building Products-Miscellaneous industry. I see a Zacks Value score of B, a Zacks Growth score of B, and a Zacks Momentum score of F. Compagnie de Saint-Gobain S.A. designs, manufactures and distributes materials and solutions for the construction and industrial markets. The company offers glazing solutions for buildings and vehicles under the Saint-Gobain, GlassSolutions, Vetrotech and SageGlass brands; plaster-based products for construction and renovation markets. Compagnie de Saint-Gobain S.A. is based in Courbevoie, France. (2) Natwest Group: This is a $14 a share stock, with a market capitalization of $57.5B. The company operates in the Zacks Foreign Bank industry. I see a Zacks Value score of F, a Zacks Growth score of D and a Zacks Momentum score of B. Natwest Group plc operates as a banking and financial services company. It provides personal and business banking, consumer loans, asset and invoice finances, commercial and residential mortgages, credit cards and financial planning services, as well as life, personal and income protection insurance. Natwest Group plc, formerly known as The Royal Bank of Scotland Group plc, is based in Edinburgh, the United Kingdom. (3) Lonza Group: This is a $68 a share stock, with a market capitalization of $49.2B. The company operates in the Zacks Medical Products industry. I see a Zacks Value score of D, a Zacks Growth score of C, and a Zacks Momentum score of B. Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. · The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. · The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. · TheCustom Manufacturing division comprises products used in pharmaceuticals sector. · The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. Why Haven't You Looked at Zacks' Top Stocks? Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year. Today you can access their live picks without cost or obligation. See Stocks Free >> Zacks Investment Research 800-767-3771 ext. 9339 support@ Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lonza Group Ag (LZAGY) : Free Stock Analysis Report NatWest Group plc (NWG) : Free Stock Analysis Report Compagnie de Saint-Gobain - Unsponsored ADR (CODYY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
